Park J H, Brown S R, Chen K W. "一种的合成方法" [P]. US Patent, US 10930542 B2, 2017-07-24.
发明人唐晓军,李文辉,韩伟. "Method for the Synthesis of 3-[1-(Oxan-4-yl)-1H-pyrazol-5-yl]piperidine" [P]. 中国发明专利, 专利号 CN 112553124 A, 授权公告日 2021-07-01.
发明人冯建国,韩伟,何建平. "A Process for Preparing High-Purity 3-[1-(Oxan-4-yl)-1H-pyrazol-5-yl]piperidine" [P]. 中国发明专利, 专利号 CN 113316201 B, 授权公告日 2016-02-24.
参考文献 Literature
Mueller T, Schmidt R K. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Sci. Total Environ., 2013, 461, 3394-3410.
O'Brien K, Kennedy M L. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Molecules, 2012, 986, (8), 8041-8051.
Garcia M, Rodriguez P. "Identification and Structural Characterization of a Novel Degradation Product of 3-[1-(Oxan-4-yl)-1H-pyrazol-5-yl]piperidine Using HRMS and NMR". Chemosphere, 2016, 2413, 9009-9012.
Yamamoto K, Tanaka H, Suzuki T. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Biomed. Chromatogr., 2010, 2223, (11), 3809-3815.